CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | GUGGENHIME ANDREW President and CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 87,474 |
| 2023-12-18 | GUGGENHIME ANDREW President and CFO | Sale 10b5-1 | −7,883 | $60.17 | $474K | 79,591 |
| 2023-12-18 | GUGGENHIME ANDREW President and CFO | Sale 10b5-1 | −117 | $60.79 | $7K | 79,474 |
| 2023-12-18 | GUGGENHIME ANDREW President and CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 392,827 | ||
| 2023-12-14 | GUGGENHIME ANDREW President and CFO | Option exercise 10b5-1 | +14,000 | $5.35 | $75K | 93,474 |
| 2023-12-14 | GUGGENHIME ANDREW President and CFO | Sale 10b5-1 | −14,000 | $60.22 | $843K | 79,474 |
| 2023-12-14 | GUGGENHIME ANDREW President and CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,000 | 400,827 | ||
| 2023-12-07 | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Option exercise 10b5-1 | +10,000 | $21.41 | $214K | 31,035 |
| 2023-12-07 | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Sale 10b5-1 | −10,000 | $56.50 | $565K | 21,035 |
| 2023-12-07 | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Shares withheld for taxes 10b5-1 | −325 | $56.78 | $18K | 20,710 |
| 2023-12-07 | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Option exercise · Stock Option (right to buy) 10b5-1 | +10,000 | 195,000 | ||
| 2023-12-01 | Wassil Jim Chief Operating Officer | Option exercise 10b5-1 | +3,000 | $2.42 | $7K | 178,935 |
| 2023-12-01 | Wassil Jim Chief Operating Officer | Sale 10b5-1 | −1,067 | $51.46 | $55K | 177,868 |
| 2023-12-01 | Wassil Jim Chief Operating Officer | Sale 10b5-1 | −1,933 | $52.51 | $101K | 175,935 |
| 2023-12-01 | Wassil Jim Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 96,555 | ||
| 2023-12-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −468 | $51.43 | $24K | 153,435 |
| 2023-12-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −841 | $52.50 | $44K | 152,594 |
| 2023-12-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −757 | $51.71 | $39K | 153,146 |
| 2023-12-01 | PICKERING GRANT Chief Executive Officer | Sale 10b5-1 | −552 | $52.68 | $29K | 152,594 |
| 2023-11-27 | Lee Jacks Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 37 of 39 · 764 trades